elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q37355762-0EA02864-0D58-4D77-B1D5-58E96A09268E
Q37355762-0EA02864-0D58-4D77-B1D5-58E96A09268E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37355762-0EA02864-0D58-4D77-B1D5-58E96A09268E
Role of lapatinib alone or in combination in the treatment of HER2-positive breast cancer
P2860
Q37355762-0EA02864-0D58-4D77-B1D5-58E96A09268E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37355762-0EA02864-0D58-4D77-B1D5-58E96A09268E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
582b164b40ec180cb9995a62201ed15f43d5c1e1
P2860
A phase II trial of trastuzumab plus weekly ixabepilone and carboplatin in patients with HER2-positive metastatic breast cancer: an Eastern Cooperative Oncology Group Trial.